Historique
Périodique
Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection
(Suivi sur 4 ans d'usagers d'héroïne incarcérés et impact d'un traitement de maintenance à la méthadone sur la mortalité, la réincarcération et l'hépatite C)
Auteur(s) :
K. A. DOLAN ;
SHEARER J. ;
B. WHITE ;
J. ZHOU ;
J. KALDOR ;
A. D. WODAK
Article en page(s) :
820-828
Refs biblio. :
30
Domaine :
Drogues illicites / Illicit drugs
Langue(s) :
Anglais
Thésaurus mots-clés
PRISON
;
FACTEUR DE RISQUE
;
MORTALITE
;
HEPATITE
;
RECIDIVE
;
TRAITEMENT DE MAINTENANCE
;
METHADONE
Thésaurus géographique
AUSTRALIE
Note générale :
Addiction, 2005, 100, (6), 820-828
Note de contenu :
fig. ; tabl.
Résumé :
FRANÇAIS :
Suivi de 1998 à 2002 de 382 usagers d'héroïne incarcérés en 1997/1998 en Australie (New South Wales). La rétention en traitement est associée à des taux plus faibles de mortalité, de réincarcération et d'hépatite C, d'où l'intérêt de la continuité du traitement de maintenance à la méthadone.
ENGLISH :
AIMS: To examine the long-term impact of methadone maintenance treatment (MMT) on mortality, re-incarceration and hepatitis C seroconversion in imprisoned male heroin users. DESIGN, SETTING AND PARTICIPANTS: The study cohort comprised 382 imprisoned male heroin users who had participated in a randomized controlled trial of prison-based MMT in 1997/98. Subjects were followed-up between 1998 and 2002 either in the general community or in prison. MEASUREMENTS: All-cause mortality, re-incarceration, hepatitis C and HIV serostatus and MMT retention. FINDINGS: There were no deaths recorded while subjects were enrolled in MMT. Seventeen subjects died while out of MMT, representing an untreated mortality rate of 2.0 per 100 person-years (95% CI, 1.2-3.2). Re-incarceration risk was lowest during MMT episodes of 8 months or longer (adjusted hazard ratio 0.3 (95% CI, 0.2-0.5; P
Suivi de 1998 à 2002 de 382 usagers d'héroïne incarcérés en 1997/1998 en Australie (New South Wales). La rétention en traitement est associée à des taux plus faibles de mortalité, de réincarcération et d'hépatite C, d'où l'intérêt de la continuité du traitement de maintenance à la méthadone.
ENGLISH :
AIMS: To examine the long-term impact of methadone maintenance treatment (MMT) on mortality, re-incarceration and hepatitis C seroconversion in imprisoned male heroin users. DESIGN, SETTING AND PARTICIPANTS: The study cohort comprised 382 imprisoned male heroin users who had participated in a randomized controlled trial of prison-based MMT in 1997/98. Subjects were followed-up between 1998 and 2002 either in the general community or in prison. MEASUREMENTS: All-cause mortality, re-incarceration, hepatitis C and HIV serostatus and MMT retention. FINDINGS: There were no deaths recorded while subjects were enrolled in MMT. Seventeen subjects died while out of MMT, representing an untreated mortality rate of 2.0 per 100 person-years (95% CI, 1.2-3.2). Re-incarceration risk was lowest during MMT episodes of 8 months or longer (adjusted hazard ratio 0.3 (95% CI, 0.2-0.5; P
Affiliation :
National Drug and Alcohol Research Centre, University of New South Wales, Sydney 2052 ; k.dolan@unsw.edu.au
Australie. Australia.
Australie. Australia.
Exemplaires
| Disponibilité |
|---|
| aucun exemplaire |